Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
all decrease » small decrease (Expand Search), a decrease (Expand Search), awd decreased (Expand Search)
Showing 1,101 - 1,120 results of 14,056 for search '(( significantly increased decrease ) OR ( significant ((all decrease) OR (fold decrease)) ))', query time: 0.69s Refine Results
  1. 1101
    The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019.

    The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1102
    Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019.

    Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1103
    Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019.

    Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1104
    ROBINS-I assessments.

    ROBINS-I assessments. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 1105
    S8 File -

    S8 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 1106
    Study populations of included studies.

    Study populations of included studies. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 1107
    Future research directions.

    Future research directions. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 1108
    PRISMA flow diagram.

    PRISMA flow diagram. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 1109
    Exercise protocols and results of included studies.

    Exercise protocols and results of included studies. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 1110
    Participant characteristics in studies of children with biopsy-proven NAFLD.

    Participant characteristics in studies of children with biopsy-proven NAFLD. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 1111
    S9 File -

    S9 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 1112
    RoB 2 assessments.

    RoB 2 assessments. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 1113
    S7 File -

    S7 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 1114
    Participant characteristics of included studies.

    Participant characteristics of included studies. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1115
    Medicare clozapine data analysis.

    Medicare clozapine data analysis. by Luke R. Cavanah (19022435)

    Published 2025
    “…For all years, there was pronounced geographic heterogeneity (average: nine-fold) in population-corrected clozapine use. …”
    Save to List
    Saved in:
  16. 1116
    PTEN KD increases chromatin accessibility.

    PTEN KD increases chromatin accessibility. by Ahmed H. Ghobashi (12705573)

    Published 2024
    “…Red dots indicate peaks with significantly increased or decreased accessibility with Log2 FC > |0.5|. …”
    Save to List
    Saved in:
  17. 1117
    Prevaelnce of different pathogens by location.

    Prevaelnce of different pathogens by location. by Amete Mihret Teshale (12072758)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1118
    Neural timescales increase with cognitive demands.

    Neural timescales increase with cognitive demands. by Isabel Raposo (21615517)

    Published 2025
    Save to List
    Saved in:
  19. 1119
    Brain regions with significant metabolic inhibition (p < 0.001, K = 50) (A) and activation (B) in rats following cocaine self-administration compared to baseline. Cluster location is both noted and indicated by coordinates in stereotaxic space (medial-lateral, anterior-posterior, and dorsal-ventral). The t-value and Z-scores were calculated from the average BGluM of all voxels within the significant clusters. KE represents the number of voxels in the respective clusters. Each cell under “Brain Region” represents a separate cluster.

    Brain regions with significant metabolic inhibition (p < 0.001, K = 50) (A) and activation (B) in rats following cocaine self-administration compared to baseline. Cluster location... by Christopher Rowan (21499924)

    Published 2025
    Save to List
    Saved in:
  20. 1120
    CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset includes variables such as demographic characteristics, clinical indicators, and measured inflammatory markers.

    CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset... by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: